Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia
NCT00360035
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelofibrosis
Interventions
DRUG:
Obatoclax mesylate (GX15-070MS)
Sponsor
Gemin X